2003 Competition Leads Patients 
Pharmaceutical Technology
SEPTEMBER 22, 2022
AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 The company now faces a highly competitive generics market for its lead drug.
Cesare Ferrari
APRIL 27, 2024
In the medical device business, the capacity for innovation is commonly regarded as a key competence and a powerful response mechanism for companies operating in our complex and highly competitive environment. Poor identification of the type of innovation can lead to a poor understanding of its characteristics and full potential.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Clarify Health
OCTOBER 3, 2022
Will posting rates online actually help patients shop around for the best, most affordable care? Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers.
Clarify Health
OCTOBER 3, 2022
Will posting rates online actually help patients shop around for the best, most affordable care? Niall Brennan , a leading expert on healthcare data use, privacy, and policy, moderated the discussion. Healthcare providers and insurers are now required to publicly disclose what they pay hospitals, doctors, and other medical providers.
European Pharmaceutical Review
DECEMBER 21, 2022
16,17 However, care must be taken to ensure that chemicals from biomass are not produced in competition with food production and do not have a negative impact on the environment or natural habitats. Production and value creation can be regionalised and decentralised, which could lead to a more resilient economic structure.
Expert insights. Personalized for you.
52 
Let's personalize your content